Alta Partners

Alta Partners
Private ownership
Industry Private equity
Predecessor Burr, Egan, Deleage & Co.
Founded 1996
Founder Dr. Jean Deleage, Ph.D., Garrett Gruener, Marino Polestra, Guy Nohra
Headquarters One Embarcadero Center
San Francisco, California, United States
Products Venture capital
Website www.altapartners.com

Alta Partners is a venture capital firm based in San Francisco which invests primarily in biotechnology and life science companies.

History

The company was founded in 1996 by Dr. Jean Deleage, Ph.D., who was also a founder of the venture capital firms Burr, Egan, Deleage & Co. (BEDCO) and Sofinnova, together with Guy Nohra, Marino Polestra, and Garrett Gruener, all former general partners at BEDCO.

Alta Partners is actively investing out of its latest early stage fund by managing directors Dan Janney, Pete Hudson, MD, and Bob More.

The company was founded in 1996 and invests in biotechnology and life science companies. According to the company website, over the past 22 years, Alta has invested in over 150 companies, including some of the leaders in the biopharmaceuticals, medical technology, healthcare services, and information technology sectors.

The firm is no longer associated with the Boston-based venture capital firm, Alta Communications, which also traces its roots to Burr, Egan, Deleage & Co.

Investment funds

Since 1996, Alta has raised nine venture capital funds including four funds in its Alta California Funds series, three funds in its Alta Biopharma Partners series, Alta Partners VIII, and most recently Alta Partners NextGen Fund I with $130 million of investor commitments.

The following is a summary of the venture capital funds raised by Alta as of 2018:

  • 1996 - $130m - Alta California Partners (Early Stage)
  • 1998 - $180m - Alta Biopharma Partners I (Late Stage)
  • 1998 - $186m - Alta California Partners II (Early Stage)
  • 2000 - $212m - Alta Biopharma Partners II
  • 2000 - $229m - Alta California Partners III (Early Stage)
  • 2003 - $300m - Alta BioPharma Partners III
  • 2004 - $184m - Alta California Partners IV (Early Stage)
  • 2006 - $500m - Alta Partners VIII
  • 2018 - $130m - Alta Partners NextGen Fund I (Early Stage)

Investments

The company has several investments in Anesiva, formerly Corgentech, beginning in November 2000 and including being the lead investor in the company's initial public offering via a US$25 million stake.[1] Anesiva is involved in the development of therapeutics for pain management.

See also

References

  1. ↑ "Alta Partners Announces $25 Million Investment in Anesiva, Inc. (ANSV)". BioSpace. BusinessWire. December 17, 2007. Archived from the original on July 16, 2011.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.